Cargando…
Exhausted-like CD8(+) T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects
Clinical trials of biologic therapies in type 1 diabetes (T1D) aim to mitigate autoimmune destruction of pancreatic β cells through immune perturbation and serve as resources to elucidate immunological mechanisms in health and disease. In the T1DAL trial of alefacept (LFA3-Ig) in recent-onset T1D, e...
Autores principales: | Diggins, Kirsten E., Serti, Elisavet, Muir, Virginia, Rosasco, Mario, Lu, TingTing, Balmas, Elisa, Nepom, Gerald, Long, S. Alice, Linsley, Peter S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934874/ https://www.ncbi.nlm.nih.gov/pubmed/33351781 http://dx.doi.org/10.1172/jci.insight.142680 |
Ejemplares similares
-
Self-reactive germline-like TCR alpha chains shared between blood and pancreas
por: Linsley, Peter, et al.
Publicado: (2023) -
Autoreactive T cell receptors with shared germline-like α chains in type 1 diabetes
por: Linsley, Peter S., et al.
Publicado: (2021) -
The safety and efficacy of alefacept in the treatment of chronic plaque psoriasis
por: Jenneck, Claudia, et al.
Publicado: (2007) -
ALEFACEPT PROMOTES COSTIMULATION BLOCKADE BASED ALLOGRAFT SURVIVAL IN PRIMATES
por: Weaver, T.A., et al.
Publicado: (2009) -
Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?
por: Zaidi, Asifa, et al.
Publicado: (2015)